Shingrix Disaster due to Endotoxin

Covid19 Jabs cause Shingles and Shingles Jabs cause multiple serious Adverse Events due to Endotoxin. Some people had them at the same time!

During the Pfizer Covid19 Process 1 clinical trial, some subjects were injected with Shingrix at the same time.

The latest data from AusVaxSafety shows that many people in Australia have done the same and suffer more than from Shingrix alone.¹

Here is a VAERS record for a lady who had both jabs on 22 December 2020. This would have been a Process 2 jab manufactured in E. Coli Bacteria.

She suffered:

• Amnesia

• Aphasia

• Blood pressure increased

• Confusional state

• Low density Lipoprotein increased

• Transient Ischaemic attack

• Vision Blurred

In a recent article Marina Zhang² reported that Eye Damage is now recognized as an Adverse Reaction of Shingrix.³ She reported on a paper (behind a paywall) by researchers at University of California San Francisco.⁴

In previous articles I showed that Endotoxin in mRNA jabs is known to cause Eye Damage and Blindness⁵ and AstraZeneca Blindness is expected.⁶

Shingrix Ingredients

Bacterial Endotoxin extract 3-O-desacyl-4'-monophosphoryl lipid A (MPL) (50 micrograms)⁷

Quillaja saponaria saponin (QS-21) (50 micrograms)

Sugar (Sucrose)

Polysorbate 80

Phosphate Buffer

Dioleoylphosphatidylcholine

Cholesterol

Glycoprotein E from Varicella Zoster Virus

The first 4 damaging ingredients are also found in NovaVax.⁸⁹

See my previous article on Polysorbate 80 for its known dangers.¹⁰

Deaths and Serious Adverse reactions

Between 13 October 2017 and 10 February 2019, an estimated 9.3 million doses were distributed and GSK received 15,638 spontaneous AE reports involving RZV.¹¹

Deaths in Australia after Shingrix

In Australia, Shingrix was authorized since 1 November 2023.¹²

TGA DAEN reported 2 Deaths after Shingrix from 516 Reports (where a single substance was suspected) of Adverse reaction to 4 February 2024.

This has now increased to 4 Deaths from 1,294 Reports (where a single substance was suspected) of Adverse reaction to Shingrix.

Guillain-Barré Syndrome warning from TGA

On 29 October 2024, the same day that Australia Health Minister Mark Butler committed $251,000,000 to a “CDC” the TGA issued an new warning on Guillain-Barré Syndrome following jabbing with Shingrix.¹³

The TGA statement says:

We have received Australian reports of Guillain-Barré Syndrome (GBS) following Shingrix vaccination.

After investigating this issue and seeking advice from an expert panel, the Product Information (PI) and Consumer Medicine Information (CMI) documents for Shingrix were updated. These changes reflect the new reporting data, recognising that GBS is a very rare adverse event.

A warning about GBS was already included in the Shingrix PI. This described the findings of an observational study in individuals aged 65 years or older which showed an increased risk of GBS (estimated 3 excess cases per million doses administered) observed during the 6 weeks following vaccination.

We began an investigation into the possible association between Shingrix and GBS in February 2024 after receiving two reports detailing this adverse event.

People are referred to as “individuals”.

Public Database:

Our public Database of Adverse Event Notifications included 13 reports of GBS following Shingrix vaccination up to 18 September 2024. The reports involved patients of both sexes. All were aged from their mid-60s to mid-80s. No deaths were reported.

What about the Secret TGA Database, how many cases there?

The TGA references a 2021 peer-reviewed paper on Shingrix causing Guillain-Barré Syndrome, published by the US FDA.¹⁴

TGA also cites a 2022 paper published by the US CDC.¹⁵

TGA also cites a 2022 paper from Kaiser Permanente.¹⁶

Read more on Guillain-Barré Syndrome caused by Endotoxin in Jabs.¹⁷

See also Aaron Siri on the Chicken Pox Jabs that don’t work.¹⁸

1. https://ausvaxsafety.org.au/shingrixr/shingrixr-safety-data-all-participants

2. Follow Marina on X. https://twitter.com/MarinatZhang

3. Marina Zhang. 23 Feb 2024. Shingles Vaccine May Increase Your Risk of Ocular Shingles Recurrence. Epoch Times. https://www.theepochtimes.com/health/shingles-vaccine-increases-risk-of-ocular-shingles-reoccurrence-5593609

4. Anushka Walia, Yuwei Sun and Nisha R. Acharya. 2024. Risk of Herpes Zoster Ophthalmicus Recurrence After Recombinant Zoster Vaccination. https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2814944

5.

6.

7.

8.

9.

10.

11. Fernanda Tavares-Da-Silva, Maribel Miranda Co, Christophe Dessart, Caroline Hervé, Marta López-Fauqued, Olivia Mahaux, Lionel Van Holle and Jens-Ulrich Stegmann. Review of the initial post-marketing safety surveillance for the recombinant zoster vaccine. https://www.sciencedirect.com/science/article/pii/S0264410X19316007

12. https://www.health.gov.au/news/national-immunisation-program-changes-to-shingles-vaccination-from-1-november-2023

13. https://www.tga.gov.au/news/safety-updates/shingrix-vaccine-and-very-rare-risk-guillain-barre-syndrome

14. Ravi Goud, Bradley Lufkin, Jonathan Duffy, Barbee Whitaker, Hui-Lee Wong, Jiemin Liao, An-Chi Lo, Shruti Parulekar, Paula Agger, Steven A Anderson, Michael Wernecke, Thomas E MaCurdy, Eric Weintraub, Jeffrey A Kelman, Richard A Forshee. 2021. Risk of Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in Medicare Beneficiaries. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2785607

15. Cara B Janusz, Tara C Anderson, Andrew J Leidner, Grace M Lee, Kathleen Dooling, Lisa A Prosser. 2022. Projected risks and health benefits of vaccination against herpes zoster and related complications in US adults. https://www.tandfonline.com/doi/full/10.1080/21645515.2022.2060668

16. Jennifer C Nelson, Ernesto Ulloa-Pérez, Onchee Yu, Andrea J Cook, Michael L Jackson, Edward A Belongia, Matthew F Daley, Rafael Harpaz, Elyse O Kharbanda, Nicola P Klein, Allison L Naleway, Hung-Fu Tseng, Eric S Weintraub, Jonathan Duffy, W Katherine Yih, Lisa A Jackson. 2022. Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data. https://academic.oup.com/aje/article/192/2/205/6747774

17.

18. Does the Chickenpox Vaccine Used in the U.S. Stop Infection and Transmission of Chickenpox?